A low-affinity antagonist reveals saturation and desensitization in mature synapses in the auditory brain stem.
Postsynaptic receptor desensitization has been observed to contribute to depression in immature synapses. However, it is not clear whether desensitization persists and causes depression in mature synapses. We investigate this issue at the endbulb of Held, the synapse made by auditory nerve (AN) fibers onto bushy cells (BCs) of the anteroventral cochlear nucleus, where depression could influence the processing of sound information. Experiments using cyclothiazide (CTZ) have implicated desensitization in endbulbs from postnatal day 16 (P16) to P21 mice, but application of γ-D-glutamylglycine (DGG) did not reveal desensitization in endbulbs >P22. To reconcile these findings, we have studied the effects of both CTZ and DGG on endbulbs from P5 to P40 CBA/CaJ mice. In paired-pulse protocols, both CTZ and DGG reduced depression in all ages at intervals <10 ms, consistent with their effects preventing desensitization. However, DGG increased depression at intervals >20 ms, consistent with DGG's use to prevent saturation. DGG application revealed receptor saturation even under conditions of very low release probability. Preventing desensitization by CTZ occluded the effects of DGG on desensitization and revealed the effects of saturation at short intervals. We developed an approach to separate DGG's effect on saturation from its effect on desensitization, which showed that desensitization has an impact during bursts of auditory nerve activity. Dynamic-clamp experiments indicated that desensitization can reduce BC spike probability and increase latency and jitter. Thus desensitization may affect sound processing in the mature auditory system.
Chanda
Soham
S
Department of Biological Sciences, State University of New York at Buffalo, Buffalo, NY 14260, USA.
Xu-Friedman
Matthew A
MA
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001306:Auditory Pathways / Q000502:physiology*; D001581:Benzothiadiazines / Q000494:pharmacology; D001933:Brain Stem / Q000502:physiology*; D003056:Cochlear Nerve / Q000187:drug effects / Q000502:physiology*; D017626:Cochlear Nucleus / Q000187:drug effects / Q000502:physiology*; D004151:Dipeptides / Q000494:pharmacology; D051379:Mice; D008808:Mice, Inbred CBA; D023421:Models, Animal; D018408:Patch-Clamp Techniques; D013569:Synapses / Q000187:drug effects / Q000502:physiology*
D001581:Benzothiadiazines; D004151:Dipeptides; C028929:gamma-glutamylglycine; C004639:cyclothiazide